Nuvectis Pharma, Inc. (NVCT)
Nasdaq: NVCT · CIK 0001875558 · United States
Every official Nuvectis Pharma, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open NVCT filings
Nuvectis Pharma, Inc. documents
- Nuvectis Pharma, Inc. 10-K 2026NVCT 10-K 2026: annual report for fiscal 2026
- Nuvectis Pharma, Inc. 10-K 2025NVCT 10-K 2025: annual report for fiscal 2025
- Nuvectis Pharma, Inc. 10-K 2024NVCT 10-K 2024: annual report for fiscal 2024
- Nuvectis Pharma, Inc. 10-K 2023NVCT 10-K 2023: annual report for fiscal 2023
- Nuvectis Pharma, Inc. 10-K 2022NVCT 10-K 2022: annual report for fiscal 2022
- Nuvectis Pharma, Inc. 10-Q 2026NVCT 10-Q 2026: quarterly report for fiscal 2026
- Nuvectis Pharma, Inc. 10-Q 2025NVCT 10-Q 2025: quarterly report for fiscal 2025
- Nuvectis Pharma, Inc. 10-Q 2024NVCT 10-Q 2024: quarterly report for fiscal 2024
- Nuvectis Pharma, Inc. 10-Q 2023NVCT 10-Q 2023: quarterly report for fiscal 2023
- Nuvectis Pharma, Inc. 10-Q 2022NVCT 10-Q 2022: quarterly report for fiscal 2022
- Nuvectis Pharma, Inc. 8-K 2026NVCT 8-K 2026: current report for fiscal 2026
- Nuvectis Pharma, Inc. 8-K 2025NVCT 8-K 2025: current report for fiscal 2025
- Nuvectis Pharma, Inc. 8-K 2024NVCT 8-K 2024: current report for fiscal 2024
- Nuvectis Pharma, Inc. 8-K 2023NVCT 8-K 2023: current report for fiscal 2023
- Nuvectis Pharma, Inc. 8-K 2022NVCT 8-K 2022: current report for fiscal 2022
- Nuvectis Pharma, Inc. DEF 14A 2026NVCT DEF 14A 2026: proxy statement for fiscal 2026
- Nuvectis Pharma, Inc. DEF 14A 2025NVCT DEF 14A 2025: proxy statement for fiscal 2025
- Nuvectis Pharma, Inc. DEF 14A 2024NVCT DEF 14A 2024: proxy statement for fiscal 2024
- Nuvectis Pharma, Inc. DEF 14A 2023NVCT DEF 14A 2023: proxy statement for fiscal 2023
- Nuvectis Pharma, Inc. DEF 14A 2022NVCT DEF 14A 2022: proxy statement for fiscal 2022
- Nuvectis Pharma, Inc. Form 4 2026NVCT Form 4 2026: insider trading filing for fiscal 2026
- Nuvectis Pharma, Inc. Form 4 2025NVCT Form 4 2025: insider trading filing for fiscal 2025
- Nuvectis Pharma, Inc. Form 4 2024NVCT Form 4 2024: insider trading filing for fiscal 2024
- Nuvectis Pharma, Inc. Form 4 2023NVCT Form 4 2023: insider trading filing for fiscal 2023
- Nuvectis Pharma, Inc. Form 4 2022NVCT Form 4 2022: insider trading filing for fiscal 2022
- Nuvectis Pharma, Inc. S-1 2026NVCT S-1 2026: registration statement for fiscal 2026
- Nuvectis Pharma, Inc. S-1 2025NVCT S-1 2025: registration statement for fiscal 2025
- Nuvectis Pharma, Inc. S-1 2024NVCT S-1 2024: registration statement for fiscal 2024
- Nuvectis Pharma, Inc. S-1 2023NVCT S-1 2023: registration statement for fiscal 2023
- Nuvectis Pharma, Inc. S-1 2022NVCT S-1 2022: registration statement for fiscal 2022
- Nuvectis Pharma, Inc. 13F 2026NVCT 13F 2026: institutional holdings for fiscal 2026
- Nuvectis Pharma, Inc. 13F 2025NVCT 13F 2025: institutional holdings for fiscal 2025
- Nuvectis Pharma, Inc. 13F 2024NVCT 13F 2024: institutional holdings for fiscal 2024
- Nuvectis Pharma, Inc. 13F 2023NVCT 13F 2023: institutional holdings for fiscal 2023
- Nuvectis Pharma, Inc. 13F 2022NVCT 13F 2022: institutional holdings for fiscal 2022
More companies